ARIES 144 Week Results: Durable Virologic Suppression in HIV-Infected Patients Simplified to Unboosted Atazanavir/Abacavir/Lamivudine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ARIES 144 Week Results: Durable Virologic Suppression in HIV-Infected Patients Simplified to Unboosted Atazanavir/Abacavir/Lamivudine

Published:2012-10 Issue:5 Volume:13 Page:233-244
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Squires Kathleen E.,Young Benjamin,DeJesus Edwin,Bellos Nicholaos,Murphy Daniel,Ward Douglas,Zhao Henry H.,Ross Lisa L.,Shaefer Mark S.,

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1310/hct1305-233

Reference19 articles.

1. Antiretroviral Treatment of Adult HIV Infection

2. Toxicity of antiretroviral therapy and implications for drug development

3. The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy

4. The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

5. Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy;AIDS;2019-06-01

2. Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia;American Journal of Epidemiology;2018-05-15

3. Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials;Open Forum Infectious Diseases;2018-04-20

4. Abacavir/lamivudina + atazanavir no potenciado en la práctica clínica diaria: doce años de experiencia;Enfermedades Infecciosas y Microbiología Clínica;2018-01

5. Abacavir/lamivudine + unboosted atazanavir in routine clinical practice: Twelve years experience;Enfermedades infecciosas y microbiologia clinica (English ed.);2018-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3